Clinical Trial Update: The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports on an early-phase (Phase 1) study evaluating the safety and efficacy of the investigational therapy VGO-Cs01p in CD7-positive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• VGO-Cs01p

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: T-ALL | EARLY_Phase 1 | Status: NOT_YET_RECRUITING